Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion type Assertion NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_head.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion description "[For women, subjects featuring the CYP1A1*2C G/G genotype and the XRCC3 Thr/Thr genotype faced a 3.1-fold greater risk (95% CI = 1.3-7.0) of colorectal cancer when compared to those featuring the CYP1A1*2C A allele and the XRCC3 Met allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_provenance.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion evidence source_evidence_literature NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_provenance.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion SIO_000772 17191090 NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_provenance.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion wasDerivedFrom befree-2016 NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_provenance.
- NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_assertion wasGeneratedBy ECO_0000203 NP586182.RA8BpEvtdOUmDx93GZsLcU3HoToCt9y_n9IQgX0AMaP-Y130_provenance.